JNJ-16241199 (R306465) is an orally active, selectivehydroxamate-based histone deacetylase (HDAC) inhibitor, with theIC50of 3.3 nM and 23 nM for HDAC1and HDAC8, respectively.JNJ-16241199induces histone 3 acetylation and strongly increases the expression of p21waf1, cip1 in A2780 ovarian carcinoma cells.JNJ-16241199 inducescell apoptosisand shows anticancer activityin a broad spectrum of human malignancies. JNJ-16241199 can be used for cancer study[1].
Molecular Weight:
413.45
Purity:
99.05
CAS Number:
[604769-01-9]
Formula:
C19H19N5O4S
Target:
Apoptosis,HDAC
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted